My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Abbott Laboratories (NY:ABT)

102.87 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EDT, Apr 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9

...

54 55 Next >

The “New BD”: A Deep-Dive Research Report on Becton, Dickinson and Company (BDX) in 2026

April 03, 2026

As of April 3, 2026, the medical technology landscape is undergoing a radical transformation, and few companies embody this evolution more than Becton, Dickinson and Company (NYSE: BDX). Known...

Via Finterra

Topics Artificial Intelligence

The Martha Transformation: A Deep Dive into Medtronic’s 2026 Pivot

April 03, 2026

As of April 3, 2026, Medtronic plc (NYSE: MDT) stands at a critical inflection point in its 77-year history. Once viewed as a lumbering healthcare conglomerate burdened by its own scale, the...

Via Finterra

Topics Artificial Intelligence Initial Public Offering Product Recall

1 Healthcare Stock on Our Watchlist and 2 We Find Risky

April 03, 2026

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in t...

Via StockStory

Abbott Laboratories (NYSE:ABT) Stands Out as a Dependable Dividend Stock ↗

April 01, 2026

Via Chartmill

Abbott Laboratories (NYSE:ABT) Passes the 'Caviar Cruise' Quality Investing Screen ↗

March 25, 2026

Via Chartmill

Abbott Laboratories (NYSE:ABT) Emerges as a Top Dividend Stock with Strong Fundamentals ↗

March 02, 2026

Via Chartmill

Wall Street's Advisory Windfall: Goldman Sachs and JPMorgan Lead the M&A Renaissance

April 02, 2026

The first quarter of 2026 has officially marked the end of the deal-making drought, ushering in a lucrative "advisory windfall" for Wall Street’s elite investment banks. Driven by a surge in...

Via MarketMinute

Topics Artificial Intelligence ETFs Economy

Best Healthcare Stocks to Buy Right Now for Long-Term Growth ↗

April 01, 2026

These "boring" businesses can slowly and consistently increase shareholders' wealth.

Via The Motley Fool

The Great Rebound: US Megadeals Surge 319% as Corporate Consolidation Returns with a Vengeance

April 01, 2026

The first quarter of 2026 has signaled a definitive end to the "deal drought" that plagued the previous three years, as American corporations embark on an unprecedented wave of consolidation. Driven by...

Via MarketMinute

Topics Artificial Intelligence Economy

The Evolution of a MedTech Giant: A Deep Dive into Becton, Dickinson and Company (BDX)

April 01, 2026

As of April 1, 2026, Becton, Dickinson and Company (NYSE: BDX), commonly known as BD, finds itself at a historic crossroads. For decades, BD was viewed as a diversified healthcare conglomerate—a...

Via Finterra

Topics Economy Lawsuit Product Recall

The Medtronic Transformation: A Deep Dive into the Future of a MedTech Titan

April 01, 2026

As of April 1, 2026, the global medical technology landscape is undergoing a profound shift, and at the center of this evolution is Medtronic plc (NYSE: MDT). Long regarded as the "sleeping giant" of...

Via Finterra

Topics Artificial Intelligence Economy Initial Public Offering

Deep Dive: Boston Scientific (BSX) and the New Era of Medical Device Dominance

March 31, 2026

Date: March 31, 2026 Introduction Boston Scientific Corporation (NYSE: BSX) finds itself at a critical crossroads this morning. After a year of record-breaking growth and the successful launch of its...

Via Finterra

Topics Lawsuit Product Recall

This Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks ↗

March 30, 2026

The Schwab U.S. Dividend Equity ETF is increasing its allocation to healthcare dividend stocks.

Via The Motley Fool

Topics ETFs Stocks

The Great Divergence: Q1 2026 M&A Hits Record $813.3 Billion Amidst "K-Shaped" Recovery

March 24, 2026

As the first quarter of 2026 draws to a close, the global mergers and acquisitions (M&A) market has delivered a paradox that is reshaping the financial landscape. Preliminary data reveals that total...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Abbott Laboratories Finalizes $21 Billion Acquisition of Exact Sciences, Redefining the Future of Cancer Diagnostics

March 23, 2026

CHICAGO — In a move that fundamentally reshapes the global diagnostics landscape, Abbott Laboratories (NYSE: ABT) officially completed its $21 billion acquisition of Exact Sciences (NASDAQ: EXAS)...

Via MarketMinute

Topics Supply Chain

2 Defensive Healthcare Stocks to Buy Right Now ↗

March 22, 2026

These two stocks make fantastic long-term holdings.

Via The Motley Fool

Topics Artificial Intelligence Economy

The Record-Breaking M&A Renaissance of 2026: Why Deal Values are Soaring as Volume Dips

March 19, 2026

As the first quarter of 2026 draws to a close, the U.S. financial landscape has been reshaped by a staggering surge in corporate consolidation. Total deal value for the quarter reached a historic...

Via MarketMinute

Topics Artificial Intelligence Economy Workforce

1 Magnificent Dividend Stock Down 22% That's a Screaming Buy Right Now ↗

March 19, 2026

Don't give up on this leading dividend payer yet.

Via The Motley Fool

The Best Dividend Stocks to Buy and Hold Forever ↗

March 12, 2026

They are relatively safe wealth compounders.

Via The Motley Fool

Topics Intellectual Property

Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks

March 11, 2026

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...

Via StockStory

Macroeconomic Headwinds and Shifting Demand Force Healthcare Giants to Trim 2026 Outlooks

March 09, 2026

As the first quarter of 2026 draws to a close, the healthcare and life sciences sectors are grappling with a "new normal" defined by capital conservatism and geopolitical friction. Industry...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

2 Profitable Stocks on Our Watchlist and 1 We Avoid

March 09, 2026

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...

Via StockStory

The Return of the Titans: M&A Volume Set to Surge 20% in 2026 Amidst "Animal Spirits"

March 04, 2026

As of March 4, 2026, the global financial landscape is witnessing a seismic shift in corporate strategy. After years of cautious maneuvering and high interest rates, the "animal spirits" of the...

Via MarketMinute

Topics Artificial Intelligence Economy World Trade

2 Reasons to Like ABT and 1 to Stay Skeptical

March 01, 2026

Over the last six months, Abbott Laboratories’s shares have sunk to $116.31, producing a disappointing 11.5% loss - a stark contrast to the S&P 500’s 7.7% gain. This was partly driven by its softer...

Via StockStory

Topics Stocks Supply Chain

Forget Tilray: This Steady Income Stock Beats Wild Cannabis Swings Every Time ↗

February 25, 2026

Abbott Laboratories is delivering double-digit percentage earnings growth along with a dependable dividend.

Via The Motley Fool

Topics Cannabis Initial Public Offering

The Great Unlocking: Medtronic’s Strategic Pivot and the MiniMed Spin-Off

February 24, 2026

Date: February 24, 2026 By: Financial Research Analyst Introduction For years, Medtronic plc (NYSE: MDT) was viewed by Wall Street as a reliable but sluggish giant—a "Dividend Aristocrat" that offered...

Via Finterra

Topics Artificial Intelligence Economy Initial Public Offering

Abbott Labs: A Boring Dividend Machine That Could Quietly Make You Rich ↗

February 23, 2026

"Boring" may be just what the doctor ordered in this volatile market.

Via The Motley Fool

Topics Artificial Intelligence

Medtronic Hits 10-Quarter High: PFA Dominance and Robotic Surges Signal a New Era for MedTech

February 23, 2026

In a definitive sign that the medical technology sector has moved past its post-pandemic stagnation, Medtronic (NYSE: MDT) reported its strongest enterprise revenue growth in ten quarters for the third...

Via MarketMinute

Topics Artificial Intelligence Earnings Economy

Boston Scientific’s $14.5B Penumbra Mega-Merger: A Strategic Reshaping of the Medtech Landscape

February 19, 2026

On January 15, 2026, the medical technology sector witnessed its most significant seismic shift in years as Boston Scientific Corporation (NYSE:BSX) announced a definitive agreement to acquire...

Via MarketMinute

Medtronic Hits Ten-Quarter Growth Peak in Q3 Fiscal 2026, Signaling Resurgence in MedTech Sector

February 19, 2026

Medtronic (NYSE: MDT) reported its strongest enterprise revenue growth in ten quarters for its fiscal third quarter of 2026, marking a significant turning point for the medical technology giant. The...

Via MarketMinute

Topics Artificial Intelligence Economy World Trade

< Previous 1 2 3 4 5 6 7 8 9

...

54 55 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.